drugset / Trial / NCT03374397

PReservation Study of Ovarian Function And Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy

NCT03374397 ↗

Phase 3 Completed 52 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare hemostasis, ovarian function preservation effect, and safety about intraoperative bleeding with SurgiGuard@ in women who underwent laparoscopic unilateral ovarian cystectomy

Timeline

Start
2017-12-06
Primary completion
2019-08-31
Completion
2019-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Surgiguard Unknown 6 g —